Zestoretic: Comprehensive Blood Pressure and Heart Failure Management
| Product dosage: 17.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.26 | $37.84 (0%) | 🛒 Add to cart |
| 60 | $1.00 | $75.68 $60.20 (20%) | 🛒 Add to cart |
| 90 | $0.92 | $113.52 $82.56 (27%) | 🛒 Add to cart |
| 120 | $0.87 | $151.36 $104.06 (31%) | 🛒 Add to cart |
| 180 | $0.82 | $227.04 $147.92 (35%) | 🛒 Add to cart |
| 270 | $0.79 | $340.56 $214.14 (37%) | 🛒 Add to cart |
| 360 | $0.78
Best per pill | $454.08 $280.36 (38%) | 🛒 Add to cart |
Synonyms | |||
Zestoretic is a fixed-dose combination antihypertensive medication containing lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, and hydrochlorothiazide, a thiazide diuretic. This dual-mechanism formulation provides synergistic effects for managing hypertension where combination therapy is indicated. It is also approved for the treatment of heart failure in patients requiring these specific agents. The combination offers simplified dosing regimens while addressing multiple pathways in blood pressure regulation, making it a valuable therapeutic option in appropriate patient populations.
Features
- Contains lisinopril (ACE inhibitor) and hydrochlorothiazide (thiazide diuretic) in fixed-dose combinations
- Available in multiple strength formulations (e.g., lisinopril/hydrochlorothiazide: 10/12.5 mg, 20/12.5 mg, 20/25 mg)
- Once-daily oral administration
- Standard tablet formulation for easy swallowing
- Manufactured under strict pharmaceutical quality control standards
- Requires prescription and medical supervision
Benefits
- Provides dual-mechanism action targeting both the renin-angiotensin-aldosterone system and sodium/fluid balance
- Offers simplified treatment regimen compared to separate pill administration
- Demonstrates proven efficacy in reducing both systolic and diastolic blood pressure
- May reduce the risk of cardiovascular events in hypertensive patients
- Can decrease edema and fluid retention through its diuretic component
- Potentially reduces pill burden for patients requiring multiple antihypertensive agents
Common use
Zestoretic is primarily indicated for the treatment of hypertension in patients for whom combination therapy is appropriate. It is not indicated for initial therapy but is reserved for cases where monotherapy has proven insufficient. The medication may also be used as replacement therapy in patients already stabilized on the individual components. Additionally, Zestoretic is approved for the treatment of heart failure in combination with digitalis and/or beta-blockers in patients requiring these specific agents. Clinical decisions regarding its use should be based on individual patient characteristics, including severity of hypertension, comorbid conditions, and response to previous antihypertensive therapies.
Dosage and direction
Dosage must be individualized based on patient response and tolerability. The usual recommended starting dose is one tablet of Zestoretic 10/12.5 once daily for patients not adequately controlled on lisinopril or hydrochlorothiazide monotherapy. Dosage may be titrated upward after 2-3 weeks of therapy based on blood pressure response. The maximum recommended daily dose is lisinopril 80 mg/hydrochlorothiazide 50 mg. Tablets should be taken orally, with or without food, at approximately the same time each day. For patients with renal impairment (creatinine clearance ≤30 mL/min), caution is advised, and alternative dosing or therapy should be considered. Elderly patients may require lower initial doses due to potential age-related changes in pharmacokinetics.
Precautions
Patients should be monitored regularly for blood pressure response and potential adverse effects. Renal function and serum electrolytes (particularly potassium, sodium, and magnesium) should be assessed before initiation and periodically during therapy. Caution is advised in patients with impaired renal function, hepatic disease, or pre-existing electrolyte imbalances. Patients should be advised to avoid excessive dehydration and to maintain adequate fluid intake. Use with caution in patients with history of angioedema, collagen vascular disease, or those undergoing major surgery. Photosensitivity reactions may occur due to the hydrochlorothiazide component; patients should use appropriate sun protection. Regular eye examinations are recommended for patients with pre-existing vision problems.
Contraindications
Zestoretic is contraindicated in patients with known hypersensitivity to any component of this product or other sulfonamide-derived drugs. It is contraindicated in patients with history of angioedema related to previous ACE inhibitor treatment. Additional contraindications include anuria, significant renal impairment (creatinine clearance <30 mL/min), and refractory hypokalemia. The medication is contraindicated in pregnancy due to potential fetal harm, particularly during the second and third trimesters. Concomitant use with aliskiren in patients with diabetes is contraindicated. Use is also contraindicated in patients with bilateral renal artery stenosis or stenosis of the artery to a solitary kidney.
Possible side effect
Common adverse reactions may include dizziness (6.5%), headache (5.2%), cough (3.9%), fatigue (3.0%), and orthostatic effects (2.4%). Gastrointestinal disturbances such as nausea (2.2%) and diarrhea (1.9%) may occur. Metabolic effects may include hypokalemia (3.0%), hyperuricemia (2.2%), and hyperglycemia. Less frequent but potentially serious side effects include angioedema (0.1%), pancreatitis, hepatic impairment, and blood dyscrasias. Dermatological reactions such as photosensitivity, rash, and pruritus may occur. Some patients may experience sexual dysfunction or mood changes. Cardiovascular effects may include orthostatic hypotension, particularly in volume-depleted patients.
Drug interaction
Zestoretic may interact with several medication classes. Concomitant use with other antihypertensive agents may potentiate blood pressure lowering effects. Nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce the antihypertensive effect and increase renal impairment risk. Potassium-sparing diuretics, potassium supplements, or salt substitutes containing potassium may increase the risk of hyperkalemia. Lithium levels may increase when co-administered with ACE inhibitors. The hypoglycemic effect of insulin and oral antidiabetic agents may be enhanced. Colesevelam and cholestyramine may reduce hydrochlorothiazide absorption. Alcohol, barbiturates, or narcotics may potentiate orthostatic hypotension.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not double the dose to make up for a missed dose. Consistent daily administration is important for maintaining stable blood pressure control. Patients should be advised to maintain a regular dosing schedule and consider using reminder systems if missed doses occur frequently. Healthcare providers should be consulted if multiple doses are missed to assess potential impact on blood pressure control.
Overdose
Overdose may manifest as excessive hypotension, which can progress to shock. Electrolyte disturbances including hypokalemia, hyponatremia, and hypochloremia may occur. Other potential manifestations include renal impairment, lethargy, and gastrointestinal symptoms. Bradycardia may develop secondary to vagal stimulation. Management involves supportive care including intravenous fluids and electrolyte replacement. Gastric lavage may be considered if ingestion was recent. Vasopressors may be required for severe hypotension. Lisinopril may be removed by hemodialysis, while hydrochlorothiazide is not effectively dialyzable. Patients should seek immediate medical attention if overdose is suspected.
Storage
Store at controlled room temperature between 20°C to 25°C (68°F to 77°F). Protect from excessive moisture and light. Keep the container tightly closed when not in use. Do not store in bathroom cabinets where humidity levels may fluctuate. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Properly dispose of any unused or expired medication according to local regulations. Do not transfer tablets to other containers that may not provide adequate protection from moisture and light.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Individual patient responses to medication may vary. Healthcare professionals should exercise their own professional judgment when considering the use of this product. Patients should consult with their healthcare provider for personalized medical advice and before making any changes to their treatment regimen. The complete prescribing information should be consulted for comprehensive details regarding use, warnings, and precautions.
Reviews
Clinical studies have demonstrated Zestoretic’s efficacy in blood pressure management. In randomized controlled trials, the combination therapy showed superior blood pressure reduction compared to monotherapy components. Patient satisfaction surveys indicate appreciation for the simplified dosing regimen. Some reviews note the convenience of combination therapy while others mention the need for careful monitoring of side effects. Healthcare providers generally report positive experiences with the medication when used in appropriate patient populations with regular follow-up and monitoring.